Hero image with Pittsburgh background pittplusme.org/study/1738

STUDY BASICS

Do you have bullous pemphigoid? If so, you may be able to participate in a study to help find out whether an investigational study drug called dupilumab is effective and safe for the treatment of bullous pemphigoid. This study will involve up to 24 in-person visits over up to 50 weeks. Compensation is provided.


IRB:
  20193092 - A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT PATIENTS WITH BULLOUS PEMPHIGOID

RESEARCH AREAS:
  Featured Research

Age Range
AGE:   18 - 90

Duration DURATION:  Up to 50 weeks
VISITS:  Up to 24 in-person visits

Location LOCATION: 
Falk Medical Building - Oakland
Compensation COMPENSATION: 

$75.00 for each completed study visit, excluding visits 11, 13, 15, 17 and 19

Phone Number PHONE NUMBER:
1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In
Search Icon pittplusme.org/study/1738
OR
Phone Number PHONE NUMBER:
1-866-438-8230

PittPlusMe.org 1-866-438-8230 PittPlusMe@pitt.edu
@PittPlusMe share tweet